INBS

Intelligent BIO Solutions Inc.

INBS stock: dilution, going concern, reverse split — what the SEC filings say, updated every weekday morning.

Nasdaq · Surgical & Medical Instruments & Apparatus · EDGAR filings (CIK 1725430) · 3 signals · 1 setups · updated Aug 20, 2026

What the filings say Pressure ▼

The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K.

Radar 59 (elevated attention) · dilution pressure low · listing risk low · governance risk low · runway n/a · strongest signal: ATM program (Aug 3, 2026)

What would confirm: 424B5/8-K announcing an offering, ATM sales disclosed in next 10-Q, or Form 4 sales by insiders ahead of it.
What would prove it wrong: Non-dilutive cash event (asset sale, grant, milestone payment), OCF turning positive, or shelf withdrawn (RW).

Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.

59Radar · attention score (0–100)

38Dilution pressure · financing + balance sheet

31Listing risk · exchange standards

33Governance risk · reporting, auditor, going concern

Setups

Independent filings stitched into a thesis, each with what would confirm and what would prove it wrong.

Forced-raise setup Pressure ▼ strength 0.70

The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K. Cash need (going-concern language) coexists with live selling machinery (atm program). Base case is a discounted raise; the question is when, not if.

Would confirm: 424B5/8-K announcing an offering, ATM sales disclosed in next 10-Q, or Form 4 sales by insiders ahead of it.
Would invalidate: Non-dilutive cash event (asset sale, grant, milestone payment), OCF turning positive, or shelf withdrawn (RW).

ATM programGoing-concern language

Analyst note

No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.

Pro on INBS

Alerts

One email the morning INBS files anything that matches your rules (types, minimum score, setups).

12-month history

Every signal and setup for INBS back a year, not just 30 days — see how the current setup built.

Full analyst notes

What we noticed, evidence with links, what could prove us wrong, red-team caveats.

Full screener + CSV

All 983 flagged companies, same-day, sortable and exportable.

Get Pro · $18.85/mo founding rate See a full Pro morning 35% off forever until Sept 30 · cancel any time

Balance sheet (XBRL)

n/acash + short-term investments

n/aestimated runway (no OCF data)

n/astockholders' equity

$11.7Mpublic float (10-K cover)

n/ashares outstanding

Runway = liquidity ÷ monthly operating burn at the latest reported period. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.

Signal timeline

Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.

Date	Signal	Evidence	Score
Aug 19, 2026	▼ Going-concern language	“going concern periodic” language in 10-K (10-K) filed 2026-08-19 filing	33
Aug 19, 2026	▼ Reverse split	“reverse split” language in 8-K (EX-99.1) filed 2026-08-19 filing	31
Aug 3, 2026	▼ ATM program	“atm” language in 8-K (8-K) filed 2026-08-03 filing	38

Other forced raise setups

VIVS VivoSim Labs, INC. · HCWB HCW Biologics Inc. · CYCU Cycurion, Inc. · BIAF bioAffinity Technologies, In · OTLK Outlook Therapeutics, Inc. · SKYE Skye Bioscience, Inc. · screener →

Not a subscriber yet? The free morning digest carries what changed and the top setups. Subscribe free → · Compare plans